stars 1 stars 2 stars 3

Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious diseases.

Selecta Biosciences Questions

The Selecta Biosciences annual revenue was $7.3 million in 2026.

Sheldon Leung is the Sr. Director, Translational Biology and Bioanalytical of Selecta Biosciences.

2 people are employed at Selecta Biosciences.

Selecta Biosciences is based in Watertown, Massachusetts.

The NAICS codes for Selecta Biosciences are [54, 3254, 325, 32541, 541, 32].

The SIC codes for Selecta Biosciences are [873, 87].

Top Selecta Biosciences Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users